Back to Search
Start Over
Dramatic improvement of myotonia permanens with flecainide: a two-case report of a possible bench-to-bedside pharmacogenetics strategy.
- Source :
-
European journal of clinical pharmacology [Eur J Clin Pharmacol] 2013 Apr; Vol. 69 (4), pp. 1037-9. Date of Electronic Publication: 2012 Oct 03. - Publication Year :
- 2013
- Subjects :
- Female
Flecainide administration & dosage
Humans
Male
Myotonia Congenita genetics
Nuclear Family
Pharmacogenetics
Treatment Outcome
Voltage-Gated Sodium Channel Blockers administration & dosage
Flecainide therapeutic use
Mutation
Myotonia Congenita drug therapy
NAV1.4 Voltage-Gated Sodium Channel genetics
Voltage-Gated Sodium Channel Blockers therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1432-1041
- Volume :
- 69
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- European journal of clinical pharmacology
- Publication Type :
- Report
- Accession number :
- 23052413
- Full Text :
- https://doi.org/10.1007/s00228-012-1414-3